Updated time: 2022-09-29 09:21:25
28A-1090313
2020-03-17
TW I775422、USP patent pending
We assessed a general in vitro methodology based on phage-displayed synthetic antibody libraries in developing diverse antibodies as affinity reagents suitable for detecting coronavirus nucleocapsid (N) protein subtypes as a model system. By examining the antibody-antigen specificities and affinities of a panel of anti-N protein antibodies against closely related N proteins from diverse strains and expression hosts with both sandwich ELISA and LFIA platforms. This method can not only be used for the rapid production of detection antibodies, but also can break through the limitations of traditional antibody technology and achieve the identification of protein antigens with high similarity.
- Antibodies are not limited to animal immune response, can produce a wide range of antibodies in a short tim.
- Produce discriminating antibodies even against highly similar antigens.
- Use different antibody combinations to detect different virus subtypes and avoid misjudgment.
- Rapid coronavirus detection kits.
- Rapid general procedure in developing LFIA-based rapid detection tests (RIDTs).
- Rapid general procedure in developing diagnostic antibodies.
An-Suei Yang
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A panel of anti-coronavirus N protein antibodies for distinguish diverse coronavirus subtypes.